NBTY Expects Potholes On Private Label Profit Road
This article was originally published in The Tan Sheet
Dietary supplement manufacturer and retailer NBTY expects increased competition in the store brand arena to drive down its gross profits, nearly two years after it made private label sales a much larger part of its business by acquiring competitor Leiner Health Products
You may also be interested in...
The Carlyle Group's planned acquisition of NBTY for $3.8 billion may not be the only private equity offer to surface for the dietary supplement giant
Johnson & Johnson's extensive recall of leading brand name analgesics spurred sales growth for Perrigo's private-label products in the category during the firm's most recent earnings period
Dietary supplement manufacturer NBTY's gross margins are unlikely to exceed 50 percent again largely because private-label product sales have nearly doubled since its acquisition of Leiner Health Products